leadf
logo-loader
viewTissue Regenix Group PLC

Tissue Regenix appoints president of its US business as its new CEO

Danny Lee has been appointed to the board of the regenerative medical devices company “with immediate effect”

Tissue Regenix Group PLC -

Tissue Regenix Group PLC (LON:TRX) has named as its new chief executive the president of its US operation.

Danny Lee has been appointed to the board of the regenerative medical devices company “with immediate effect”.

Before joining Tissue Regenix last January, he was CEO for Scaffold Biologics and Aperion Biologics.

He will succeed Gareth Jones, formerly chief financial officer, who was made interim CEO last August. While he is stepping down from the board, Jones is staying with the company until the end of the year to ensure an “orderly handover”.

“I would like to thank Gareth for his leadership during a transitional period for the company,” said Lee.

“I am honoured to be selected to lead this company. Throughout my career, I have been passionate about building and growing companies in the regenerative medical space.

“During my tenure at the company, I have had the opportunity to appreciate the impact created by our proprietary products and the exceptional capabilities of our team.”

Quick facts: Tissue Regenix Group PLC

Price: 0.57 GBX

AIM:TRX
Market: AIM
Market Cap: £40.09 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Tissue Regenix Group PLC named herein, including the promotion by the Company of Tissue Regenix Group PLC in any Content on the Site, the...

FOR OUR FULL DISCLAIMER CLICK HERE

Morning Report: FTSE 100 heads higher as markets welcome easing of restrictions

Headlines from the Proactive UK newsroom. The FTSE 100 rose 21 points to 6,957 as markets welcomed more easing of coronavirus lockdown measures across Europe despite some confusion in the UK. UK prime minister Boris Johnson, though, is being pressed for more clarity on the relaxation of UK...

on 11/5/20

2 min read